Introduction
Uranium is a toxic and radioactive heavy metal. It is naturally available in the earth's crust, and can be found in, e.g. food, groundwater, and mineral resources. 1 Uranium distributed in the environment may enter the human body via various ways. In vivo uranium is toxic to bones, kidneys, lungs, and the brain, [2] [3] [4] [5] [6] and can even cause cancer in the human body. In serum, uranium predominantly exists in the uranyl (UO 2 2+ ) form, [7] [8] [9] [10] and displays an affinity constant in the range of 10 7 to 10 13 to combine with serum transferrin (sTf), 9, 11, 12 and the uranyl-sTf complex can form a weak interaction with the sTf receptor to constitute a potential channel for the transportation of uranyl from serum to cell.
13
Serum transferrin is a glycoprotein of about 80 kDa, and its major function is to transport Fe 3+ in human cells. 14 It exists in the form of a single chain with two lobes, C and N lobes, consisting of 700 amino acid residues. Each lobe has an ironbinding site constituted by four residues, including two tyrosines (Tyr), one histidine (His), and one aspartate (Asp). 15 The N-lobe of transferrin in its holo state has been crystallized 16 and its binding site with ferric cation bound is shown in Fig. 1 to highlight how the key residues assembly to accommodate the ferric cation. When the transferrin is in its apo state, the four ligands open up in the aqueous medium. [17] [18] [19] The apo state can also form complex with other metals besides iron, such as aluminum, titanium, bismuth, gallium, cobalt, uranium, and so on.
20-22
Uranyl differs from Fe 3+ in its linear geometry with two O yl atoms at the axial coordination sites. When coordinating with sTf, since the axial positions of uranyl are occupied by O yl groups only three ligands may bind with uranyl in the equatorial plane in addition to a synergistic bidentate ligand, and the binding region of the complex is semi-closed. 10 In a previous study, Vidaud et al. obtained the FTIR spectra of the uranyltransferrin complex, which showed the His249 does not connect to the uranyl ion. 23 This was later supported by a B3LYP study of the vibrational frequencies of potential QM models. 24 The stronger interaction between O and U than that between N and U was also observed in a survey of crystal structures of proteins with uranyl bound deposited in the databases. 25 In the work of Vidaud et al., 23 the binding of uranyl has been compared to that of Fe
3+
, and a structural model was proposed to illustrate the semi-open conformation of uranyl-sTf complex which may be responsible to its weaker interaction with the sTf receptor than that of Fe 3+ -sTf. In that work, the Asp63 and the synergistic anion CO 3 2À were identied to interact with uranyl differently compared to Fe 3+ , while lack of details at the molecular level in their interaction modes with uranyl. The burgeoning application of ssion energy in civilian use raises serious concerns on the environmental and health consequences. The insufficient knowledge on the in vivo migration mechanism of uranyl leaves the public in fear on the operation of nuclear plant, but also makes it difficult to implement a rescue strategy to cope with unexpected situations. This motivated the current work, in which we employed density functional theory method to investigate the binding process of uranyl to sTf in serum. Based on previous work from both experimental 15 and computational 24, 26, 27 sides, we assumed a stepwise pathway started from uranyl tricarbonate, during which the U atom remains in hexa-or penta-coordinated. This work is expected to shed light on our understanding of the in vivo behavior of uranyl and has implications on protein engineering targeting at improved binding kinetics and thermodynamics of uranyl and biomolecules or at the development of decorporation agents.
Computational details
Density functional theory (DFT) methods have been used [28] [29] [30] [31] in the studies of actinide chemistry. In this work, B3LYP functional, [32] [33] [34] [35] as implemented in Gaussian 09 package, 36 was employed to conduct the calculations. Uranium was described by a quasi-relativistic pseudopotential according to Dolg, et al., [37] [38] [39] denoted as ECP60MWB, which treats inner 60 electrons in the core shells, together with the optimized basis set for the valence shells. For the other atoms, a triple-z-quality basis set with diffuse and polarization functions, denoted as 6-311++G(d,p), was used. All stationary points were fully optimized, followed by vibrational frequency calculations to identify the nature of each structure to be a minimum or a transition state. Intrinsic reaction coordinate (IRC) 40 calculations were carried out to guarantee that the transition states are in the right reaction paths. Correction to the Gibbs free energy of solvation was done by a THERMO program according to Fang.
41
All discussions about the thermodynamics of the reaction pathways are based on the corrected Gibbs free energies. Simplied models cultivated from the binding site of sTf were used to study the binding mechanism of uranyl. Only the functional groups of the residues that are responsible for the binding of uranyl to sTf were considered, and the solvent environment was handled by using the polarizable continuum model (PCM) 42, 43 with a dielectric permittivity of 78.3553 (water). In the models, the Tyr was mimicked by p-cresol (HTyr*) and Asp by acetate (HAsp*). The protonation states of the residues were determined according to their pK a values, which are 9.84 AE 0.11 for Tyr and 3.67 AE 0.04 for Asp, respectively, 44 thus at pH ¼ 7, the Tyr exists in its protonated state while Asp in its deprotonated state.
Results and discussion
Previous studies 45, 46 show that the in vivo uranyl may exist in the free form, or binding with target proteins, e.g. transferrins, or deposited in bones. The general form of free uranyl in serum appears as uranyl tricarbonate complex (UO 2 (CO 3 ) 3 4À ), which was used as the starting material in the present study. In the holo form of transferrins, the uranyl interacts with the protein via the coordination with three amino acid residues, i.e. two tyrosine and one aspartic acid. We consider the binding process of one lobe of transferrins. Assuming the binding of uranyl to the transferrin proceeds in a stepwise manner, three pathways were investigated, differing in the sequence of the residues to coordinate to uranyl: Tyr* / Tyr* / Asp* (denoted as YYD), Tyr* / Asp* / Tyr* (YDY) or Asp* / Tyr* / Tyr* (DYY). In the following, these three pathways will be analyzed and compared.
I. Pathway YYD: Tyr* / Tyr* / Asp* Along this pathway, the whole reaction starts two sequential ligand exchange steps of carbonate by HTyr*. The released excess coordination site of uranyl is then occupied by an Asp* residue nearby. Initially, the exchange of carbonate by the rst Tyr* may happen in three channels, i.e. either by a direct ligand exchange between the two groups (channel I, eqn (1)), or assisted by a hydronium ion in aqueous phase (channel II, eqn (2) and (3)), or a direct ligand exchange between hydrolyzed uranyl tricarbonate species and Tyr* (channel III, eqn (4) and (5)). These three channels are elucidated as below: Channel I:
Channel II:
Channel III:
According to the calculations, the direct ligand exchange reaction (channel I) is an exothermic process with a free energy change of À8.0 kcal mol À1 (Table S1 † (4) is moderately endothermic by 2.2 kcal mol À1 .
The HTyr* then approaches the uranyl to replace the hydroxide anion (eqn (5)). This reaction is thermodynamically favorable in view of its exothermicity of À10.2 kcal mol À1 . Based on the above data, below we consider the reaction initialized by the channel I. The channel III was also investigated and the data are provided in ESI. † Along the channel I, starting from 1a and HTyr*, the rst ligand exchange reaction is described as a four-step process, including the breakage of U-O4 bond (TS1a), the proton transfer from HTyr* to O5 (TS2a), the ligand exchange of HCO 3 À by Tyr* (TS3a), and the HCO 3 À release (TS4a), as shown in Fig. 2 .
The free energy prole is plotted in Fig. 3 . When approaching 1a, HTyr* may rst form a hydrogen bond (H-bond) with one carbonate group (COM1a), which is thermodynamically favorable by 7.4 kcal mol
À1
. In COM1a, the HTyr* interacts with the carbonate group via an H-bond between H6 (HTyr*) and O5 (carbonate). We have also checked the possibility for an H-bond between H6 and O2/O4, which is given in Fig. S4, † from the Tyr* group, as indicated by the variation of the Mayer atomic bond orders (MBO) of H6-O5, which is to be formed, and H6-O7, which is to be broken, from 0.123 and 0.568 in INT1a to 0.378 and 0.235 in TS2a to 0.515 and 0.177 in INT2a, respectively (Fig. 4b) . The protonated carbonate group is easily replaced by the Tyr* anion via TS3a. In TS3a, the imaginary vibration frequency corresponds to the asymmetric stretching mode of the U-O7 (Tyr*) and U-O2 (carbonate), suggesting the coordination of Tyr* and the dissociation of bicarbonate happened simultaneously. The free energy barrier to this process is 13.1 kcal mol À1 and this step is endothermic by 9.4 kcal mol
. The detached HCO 3 À group then leaves, and gives the penta-coordinated UO 2 (CO 3 ) 2 (Tyr*) 3À complex (INT4a). In INT4a, the Tyr* is coordinated to U in a h 1 -manner, with a U-O7 bond length of 2.306Å. Note that, the coordination of the second deprotonated phenolate ligand (INT2b / TS3b / INT3b) is exothermic, which is in contrast to that of the rst one (INT2a / TS3a / INT3a). This is because that INT2b is less negatively charged than INT2a. In the meantime, uranyl has coordination site ready to receive the deprotonated phenolate ligand. This leads to a thermodynamically more favorable formation of INT3b than INT3a.
In Fig. 4 , the uctuations of the natural charges of U and the coordinating O atoms of the ligands and the MBO of key bonds along the channel I are monitored, which are consistent with the structural evolution along the reaction. Considering the proton transfer step as an example, it can be seen that accompanying the proton transfer from HTyr* (O7) to one carbonate ligand (O5), there is marginal change in the atomic charges residing on these two atoms and the O4 atom. For the other atoms, the atomic charges remain roughly constant during the reaction. This suggests that the complex may adapt to the new chemical environment during the ligand exchange and reach its equilibrium state quickly. The monitoring of the MBO clearly shows the cleavage of U1-O2, U1-O4, and O7-H6 bonds, whose MBO values evolve from 0.4-0.6 to around 0.0, and the formation of O5-H6 and U1-O7 bonds.
The newly formed INT4a may experience a second ligand exchange reaction to have one of the rest two carbonate groups replaced by another HTyr* ligand. A process similar to the rst ligand exchange reaction was identied, as shown in Fig. 2 .
Similar to the binding of the rst Tyr*, along the binding of the second Tyr* ligand, there is also no signicant charge transfer (within 0.28e) during the reaction, as seen in Fig. 4c , and the evolution of the Mayer atomic bond order of key bonds (Fig. 4d) clearly shows that the proton transfer from O14 (HTyr*) to O12 (CO 3 2À ) happens prior to the U-O14 bond formation and the U-O11 bond cleavage. Upon the dissociation of O14/H13-O12 hydrogen bond in INT4b, a water molecule close to uranyl may attach to U to keep it penta-coordinated in its equatorial plane. This gives the intermediate UO 2 (CO 3 )(H 2 O)(Tyr*) 2 2À (1c, Fig. 2 ). It may interact to the neighboring Asp carboxylate group, which is modelled by Asp* ligand here. The reaction is a thermoneutral process with the free energy of Prod being 1.1 kcal mol À1 lower than 1c. The free energy prole of this whole process of YYD is plotted in Fig. 3 . In summary, following the pathway YYD starting with channel I, the rate-determining step is the coordination of the rst Tyr* ligand (TS3a) with a relative free energy of 8. , we located the stationary points of the second and the third ligand exchange steps in the pathway YDY. The optimized structures are shown in Fig. 5 for the two sequential steps, and the free energy prole of process YDY is plotted in Fig. 6 .
For the coordination of Asp*, as the carboxylate group is in its deprotonated state, we did not consider the release of one Fig. 2 The schematic structures of stationary points following the YYD pathway along with key geometrical parameters (bond lengths inÅ, and bond angles and dihedral angles in degree). The numbering of key atoms is given in COM1a, COM1b, and TS1c, and the aromatic C atom of pcresol that is bonded to its hydroxyl group is numbered as 8 in the first HTyr* ligand or 15 in the second one. The aliphatic hydrogen atoms of Asp* are omitted for simplicity. The solid lines represent the normal covalent or coordination bonds, and the dash lines represent the partially cleaved/formed bonds or weak interactions. approaching to the negatively charged UO 2 (CO 3 ) 3 4À complex which blocks this channel. This suggests that the direct exchange of CO 3 2À by Asp* is hard to happen.
There exists another possibility with the exchange mediated by a water molecule, which may thus alleviate the electrostatic repulsion. It involves two reactions below:
This clears space in the surrounding of U atom to allow Asp* to approach uranyl. The DG of eqn (7) is calculated to be 11.3 kcal mol À1 . These data suggest that the DYY pathway cannot compete against the YYD pathway under physiological conditions.
IV. Discussion
We note that in an earlier B3LYP study, 24 an uranyl complex was constructed with the equatorial plane of U atom tetracoordinated, where the Asp and the carbonate groups coordinate with uranyl as monodentate ligands. In a well conned and limited space, such a conformation may represent a special case for uranyl to adapt to the chemical environment constructed by protein due to the constraints of protein backbone. In recent years, it is established knowledge that in aqueous phase, uranyl prefers to adopt a penta-coordinated conformation in its equatorial plane. In the case of sTf, the uptake of the uranyl triggers a domain rotation of the protein around an axis crossing the hinge site. This means that the binding site is not uniquely dened prior to the binding of uranyl, and the exible residues may adjust their orientations to reach an optimal binding state with uranyl. Thus, in this work, we have considered a hexa-or penta-coordinated conformation of the uranyl in its equatorial plane, 1 where the synergistic anion binds to uranyl in a k 2 manner. According to our calculations, the whole reaction is exothermic, suggesting such a treatment is reasonable in view of thermodynamics. As mentioned above, the free energy barrier to the ratedetermining step of pathway YYD is 13.1 kcal mol À1 which corresponds to the ligand exchange of the rst Tyr* with HCO 3
À
. For the pathway YDY, the binding of the Asp* ligand costs more energy of 20.1 kcal mol À1 (Asp*) and appears as the rate-determining step. These data show that when loading to sTf, the uranyl tricarbonate favors to coordinate to two Tyr residues sequentially rst prior to its interaction with Asp, although Asp is ready to interact with uranyl while Tyr requires to be deprotonated before coordinating to uranyl. Note that, in serum, uranyl exists mainly in its tricarbonate complex form, and any ligand exchange process requires the release of one or two of its carbonate ligands. Keeping this in mind, the proton on the phenol group offers a "dragging force" to weaken the interaction between the coordinated carbonate ligand and uranyl and facilitate its leaving to trigger the ligand exchange reaction, in Chinese idiom, mislead a tiger (carbonate) to leave the mountains it based (uranyl) by a plot (proton) in order to conquer its territory (the coordination site). This benets the Tyr residue to grab uranyl nearby. The deprotonated Asp residue does not have this "bait", and cannot compete against Tyr residue in their coordinating with uranyl which is under the protection of the negatively charged carbonate ligands. In other words, the approach of Asp to uranyl is posterior to the binding of two Tyr residues, and the YYD pathway is the most plausible mechanism for the ligand exchange of uranium tricarbonate. An overview of the YYD pathway is shown in Fig. 8 . According to our calculations, the whole process is exothermic, either along the YYD or the YDY pathway, by À7.2 kcal mol À1 . This suggests that the capture of uranyl by sTf is a thermodynamically favorable process. To understand the bonding nature of the starting material UO 2 (CO 3 ) 3 4À and the product UO 2 (CO 3 )(Tyr*) 2 (Asp*) 3À , we analyzed the bonding properties of the coordination bonds using QTAIM topological analysis technique. Four descriptors are used to compare the coordination bonds in the two complexes, and these include the electronic density r b and its Laplacian V 2 r b , the energy density Fig. 7 The schematic structures of U-3CO 3 -Asp* and U-2CO 3 -Asp* with key geometrical parameters (bond lengths inÅ). . These values are collected in Table 1 .
As seen in Table 1 
Conclusion
The binding process of uranium to transferrin has been investigated by density functional theory method, and three stepwise pathways have been compared, differing in the sequence of the three amino acid residues, which are simplied as two HTyr* and an Asp*, in a series of ligand exchange reactions. The calculations identied the Tyr* / Tyr* / Asp* (YYD) pathway as the optimal pathway. Along this pathway, the HTyr* residues may grab the free UO 2 (CO 3 ) 3 4À aqueous species, and the proton transferred from HTyr* to the bound CO 3 2À ligand triggers the ligand exchange reactions. The Asp* residue builds interaction with uranyl in the end to anchor the uranyl in the binding site. This is also consistent with the experimental hypothesis that the Asp is relevant to the semi-open conformation of the uranylsTf complex. The other two pathways, i.e. Tyr* / Asp* / Tyr* (YDY) and Asp* / Tyr* / Tyr* (DYY), in which the negatively charged Asp* coordinates to uranyl prior to the binding of one or both neutral HTyr* ligands, suggests that the excess ligands CO 3 2À to be replaced play a key role in determining the uptake mechanism of uranyl by sTf. The deprotonated Asp* does not have a proton to perturb the strong interaction between CO 3 2À and uranyl, which makes it energy demanding to repel one of the CO 3 2À ligands in order to release coordination site. In addition, in its carbonate complex, the positive charge of uranyl is already neutralized by the carbonate ligands, and the approaching of Asp* also brings electrostatic repulsive interaction, which disfavor its binding when uranyl is tri-or di-carbonated. In summary, this work identied an optimal pathway for the uptake of uranyl by sTf at around pH ¼ 7.0, and claried that this is determined by synergistic ligands CO 3 2À . This shows that at low pH, due to the strong preference of carbonate to be protonated, the UO 2 (CO 3 ) 3 4À is no longer the predominant species, 47 and the YYD mechanism may no longer dominate. This work thus helps improve our understanding on the in vivo migration of uranyl by providing detailed mechanism at the molecular level, and sheds light on the protein engineering and the design of decorporation reagents toward the enhanced capture of uranyl in specic pH range. 
